Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Michail, Vikelis"'
Autor:
Maria Papasavva, Michail Vikelis, Vasileios Siokas, Martha-Spyridoula Katsarou, Emmanouil V. Dermitzakis, Athanasios Raptis, Efthimios Dardiotis, Nikolaos Drakoulis
Publikováno v:
Neurology International, Vol 15, Iss 3, Pp 1117-1128 (2023)
Migraine is a common primary headache disorder with both environmental and genetic inputs. Cumulative evidence indicates an association between vitamin D and headache. Unravelling the precise role of vitamin D and its receptor in the pathophysiology
Externí odkaz:
https://doaj.org/article/9279c1554d644b64add749f331e01405
Autor:
Emmanouil V. Dermitzakis, Andreas A. Argyriou, Konstantinos Bilias, Evangelia Barmpa, Sofia Liapi, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Michail Vikelis
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 10, p 2768 (2024)
Objective: The Greek Society of Migraine and Headache Patients conducted its third in-line population web-based survey in 2023 to ascertain if the burden of the disease and the patients’ satisfaction with conventional and novel migraine therapies a
Externí odkaz:
https://doaj.org/article/cd47dd64ad34422aa380c4059eacb713
Autor:
Dimitrios Rikos, Michail Vikelis, Emmanouil V. Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Jobst Rudolf, Anna P. Andreou, Andreas A. Argyriou
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 1964 (2024)
Objective: Phase II/III randomized clinical trials (RCTs) are vulnerable to many types of bias beyond randomization. Insights into the reporting quality of RCTs involving migraine patients treated with monoclonal antibodies targeting the calcitonin g
Externí odkaz:
https://doaj.org/article/d6d0c3fedac14b6e9e4d9890b4676664
Autor:
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Publikováno v:
Toxins, Vol 16, Iss 2, p 106 (2024)
Background: We primarily aimed to ascertain whether treatment with OnabotulinumtoxinA (BoNTA) might influence the extent of the interictal burden and cutaneous allodynia in patients with chronic migraine (CM). Methods: Seventy CM patients, who receiv
Externí odkaz:
https://doaj.org/article/b931fb576d9b404e8011c5082a7dfa1a
Autor:
Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, Konstantinos C. Spingos, Konstantinos Bilias, Michail Vikelis
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract The Greek Society of Migraine and Headache Patients (GSMHP), maintaining a strong commitment to research and information, conducted its second web-based online survey named "Migraine in Greece—2020", following its first one conducted in 20
Externí odkaz:
https://doaj.org/article/acdac6bc40a14f63ab931e2854b42eef
Autor:
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Andreas A. Argyriou
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 2, p 386 (2024)
Objective: To investigate whether the incidence of triggers, prodromal symptoms, hypersensitivity symptoms accompanying headache and responses to triptans were modified during a continuous 9-month fremanezumab therapy for migraine prophylaxis. Patien
Externí odkaz:
https://doaj.org/article/4e3ece67b0c3433cbe830243e2ab69df
Autor:
Georgia Xiromerisiou, Ioannis C. Lampropoulos, Emmanouil V. Dermitzakis, Michail Vikelis, Chrysoula Marogianni, Dimitrios Mysiris, Andreas A. Argyriou
Publikováno v:
Toxins, Vol 15, Iss 9, p 539 (2023)
We sought to assess the efficacy of combining onabotulinumtoxinA (BoNTA) as add-on therapy to carbamazepine or oxcarbazepine in treatment-refractory patients with trigeminal neuralgia (TGN) who failed to respond (less than 30% response rate) to adequ
Externí odkaz:
https://doaj.org/article/8456b17fbd7547b8a49e5cfc7bbc4db8
Autor:
Maria Papasavva, Michail Vikelis, Vasileios Siokas, Martha-Spyridoula Katsarou, Emmanouil V. Dermitzakis, Athanasios Raptis, Aikaterini Kalliantasi, Efthimios Dardiotis, Nikolaos Drakoulis
Publikováno v:
Frontiers in Neurology, Vol 13 (2023)
IntroductionMigraine is a complex disorder with genetic and environmental inputs. Cumulative evidence implicates oxidative stress (OS) in migraine pathophysiology while genetic variability may influence an individuals' oxidative/antioxidant capacity.
Externí odkaz:
https://doaj.org/article/9f8b8e1eff844683a8211f3064cd27cf
Autor:
Michail Vikelis, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Andreas A. Argyriou
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 13, p 4526 (2023)
Objective: this post hoc analysis aimed to evaluate the efficacy of fremanezumab in difficult-to-treat chronic migraine (CM) patients with and without psychiatric comorbidities (PCs), mainly anxiety and/or depression. Methods: We assessed data from C
Externí odkaz:
https://doaj.org/article/da4f41d7e6174dd7bf067a1c0ba010cf
Autor:
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 9, p 3218 (2023)
Objective: To define, in a real-world population of patients with high-frequency episodic (HFEM) or chronic migraine (CM), the predictive role of socio-demographic or phenotypic profiling of responders to fremanezumab. Patients and methods: Two-hundr
Externí odkaz:
https://doaj.org/article/bec97c87539f490082168e131dc64e44